A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

Clinical trial NCT01650701 · COMPLETED

Trial details

NCT number: NCT01650701
Sponsor: The Lymphoma Academic Research Organisation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2012-02-01
Primary completion: 2017-05-31
Enrollment: 1030

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.